Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.

Uplizna

Inebilizumab

InebilizumabCD19-directed Cytolytic Antibody [EPC]1 Variant

Clinical Data

Brand Name

Uplizna

Generic Name

Inebilizumab

Active Ingredient

Inebilizumab

Drug Classes

CD19-directed Cytolytic Antibody [EPC]

Important Notice

This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Uplizna, you must consult a qualified healthcare professional.

Available Variants (1)

Different strengths and dosage forms

Strength	Form	Route	NDC
10 mg/mL	INJECTION	INTRAVENOUS	75987-150